ftInvstr
ALIVUS · Healthcare ₹1369.9 -3.53% Mkt Cap ₹16847 Cr overvalued

ALIVUS

Healthcare Drug Manufacturers - Specialty & Generic
₹1369.9
-3.53% today · 30d +3.66%
as of 2026-09-04
Price · Daily Candles
“Alivus rides strong Q2 profit surge as FIIs nibble and the stock nears 52-week highs.”
Alivus reported a significant 31.71% YoY net profit growth in Q2 2026, reaching ₹160 Cr, despite revenue growing at a more modest 6.41%. The company maintains a high profit margin of 23.28% and a robust operating profit margin (OPM) of 35.32%, showcasing efficiency even as Free Cash Flow (FCF) growth predictions indicate potential future compression.
BULL CASE
+Q2 2026 net profit jumped 31.71% YoY to ₹160 Cr, significantly outpacing revenue growth.
+The company's OPM improved by 5.64% YoY in Q2 2026, reaching 35.32%.
+FIIs increased their stake by 0.25% QoQ in Q2 2026, reaching 5.54%.
+The stock is currently trading only 1.91% below its 52-week high of ₹1358.0, indicating strong recent momentum with 1-month returns at 16.54%.
BEAR CASE
Revenue growth in Q2 2026 was a modest 6.41% YoY, indicating a reliance on cost control for profit expansion.
ML predictions forecast a severe FCF compression, with 1-year FCF growth in the rolling 4-year period at -40.65% in H1.
DIIs decreased their stake by 0.10% QoQ in Q2 2026.
Alivus's PE (TTM) of 27.15 is above sector peer ZYDUSLIFE (21.85) and LUPIN (20.43).
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹640 Cr
+6.41% YoY
NET PROFIT
₹160 Cr
+31.71% YoY
OPM
35.32%
+5.64pp YoY
EPS
₹13.04
PE 27.15
Intrinsic value · DCF ₹225.99 · Margin of safety -83.5% (overvalued) · FCF yield 1.53%
◇ Sector Position
Alivus (PE 27.15) trades at a premium to peers like ZYDUSLIFE (PE 21.85) and LUPIN (PE 20.43), but with a lower ROCE compared to LUPIN (34.06%).
PEERPEROCE %
ALIVUS27.15
SUNPHARMA38.4121.44
DIVISLAB82.0221.56
CIPLA35.1218.37
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
76
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation REASONABLE 60
Growth STEADY 65
Profitability HIGH 90
Technicals STRONG 70
Risk LOW 80
Key Stats
TTM PE
27.15
P/B
4.91
52W HIGH
₹1493.8
OFF HIGH
-8.29%
DIV YIELD
0.37%
MKT CAP
₹16847 Cr
◉ Active Signals
MACDNeutral-5.7867
RSI(14)Neutral55.18
Street Consensus
4 analysts
₹1335.0
mean target
Low ₹1235.0Now ₹1369.9High ₹1400.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ALIVUS and at what entry.

Sign up freeSign in